markdown

Gleamer Company Research Report

Company Overview

Name: Gleamer

Mission: To provide radiologists and clinicians with the most comprehensive AI companion in their routine care, facilitating reliable diagnoses and optimizing examination reading and processing time.

Founded: 2017

Founders: Christian Allouche, Alexis Ducarouge, Dr. Nor-Eddine Regnard

Key People:

Christian Allouche, Chief Executive Officer

Alexis Ducarouge, Chief Technical Officer

Dr. Nor-Eddine Regnard, Chief Medical Officer

Nicolas Jirikoff, Chief Business Officer

Noé Poyet, Chief Financial Officer

Antoine Tournier, Chief Compliance Officer & DPO

Rémi Quilliet, VP Product

Headquarters: 5 avenue du Général de Gaulle, 94160 Saint Mandé, France

Number of Employees: No information is available

Revenue: Annual recurring revenue of €7 million

Known For: Developing AI software to assist radiologists in diagnosing and detecting bone trauma lesions.

Products

BoneView

Description: This AI application assists in the interpretation of bone trauma X-rays, pinpointing fractures, effusions, dislocations, and bone lesions.

Key Features: Recognized for scientific rigor, efficiencies in global bone trauma X-ray interpretations, and clinical validation winning the prestigious 2022 Alexander Margulis Award for scientific excellence.

ChestView

Description: Enhances the detection of urgent findings such as pneumothorax, pleural effusion, and consolidation on chest X-rays.

Key Features: Co-developed with AP-HP, it is widely used worldwide, assisting in rapid triage of chest X-rays with high sensitivity and specificity.

BoneMetrics

Description: Automates musculoskeletal measurements, providing precision on X-ray and EOS acquisitions.

Key Features: Standardizes workflows with precision matching MSK radiologist expertise, enhancing data reliability and clinician satisfaction.

BoneAge

Description: Automates bone age assessment by utilizing the Greulich & Pyle atlas method.

Key Features: Reduces variability, saves time, and improves precision compared to traditional methods.

Recent Developments

Revenue and Expansion:

Raised €27 million in a Series B funding round.

Plans to expand product offerings to CT scans and mammography and expand in Europe and the U.S.

Product and Market Expansion:

Intention to extend services to 2,000 sites spanning 35 countries by 2025.

Expanding portfolio with six new products, now targeting 60-70% of radiologists' routine needs.

Recognition and Achievements:

CEO Christian Allouche was named among the 40 under 40 driving the healthcare sector in France.

Recipient of multiple awards including "Best New Radiology Vendor" at EuroMinnies 2023 and an Alexander R. Margulis Award for Scientific Excellence.

Partnerships:

Strategic partnerships with entities like Siemens Healthineers and a multi-faceted approach for growth in the Middle East.

Validations and Certifications:

Products like BoneView, ChestView, and BoneMetrics have received certifications such as CE and FDA clearances, ensuring compliance and reliability globally.

Insights and Achievements

Awards: Best Startup nominee for 2023 Prix Galien USA, Top 10 of 2023 Google's EMEA AI contest, and the Health of the Future Award 2023.

Scientific Contributions: Robust academic presence with over 25 publications and 80 clinical studies cementing their scientific leadership in AI-driven medical imaging solutions.